The inhibition of sulphur dioxide-induced bronchoconstriction in asthmatic subjects by cromolyn is dose dependent.
D001249:Asthma / Q000503:physiopathology*; D001986:Bronchial Spasm / Q000517:prevention & control*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D013458:Sulfur Dioxide
D013458:Sulfur Dioxide; D004205:Cromolyn Sodium